HK
Harshal Kanubhai Shah
About Harshal Kanubhai Shah
Data last updated:
Harshal Kanubhai Shah is a Designated Partner at Fusegen Therapeutics Llp (since 2026) and Director at Forefront Pharmalabs Private Limited (since 2024). The companies operate in Paper.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Fusegen Therapeutics Llp ADA-9911 | Designated Partner | 07 Aug 2026 | 2026 | Active | |
| Forefront Pharmalabs Private Limited U21002GJ2024PTC148820 | Director | 19 Feb 2024 | 2024 | Active |
Board colleagues of Harshal Kanubhai Shah
| Name | DIN | Company | Designation |
|---|---|---|---|
| Vijay Kumar Ranka | 02938775 | Fusegen Therapeutics Llp | Designated Partner |
| Narendra Prabhudas Chotai | 10514207 | Forefront Pharmalabs Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Harshal Kanubhai Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Harshal Kanubhai Shah
Harshal Kanubhai Shah currently holds 2 directorships: Fusegen Therapeutics Llp (Designated Partner, since 07 Aug 2026); Forefront Pharmalabs Private Limited (Director, since 19 Feb 2024).
Harshal Kanubhai Shah was first appointed on 19 Feb 2024 as Director at Forefront Pharmalabs Private Limited. The most recent appointment on record is 07 Aug 2026 at Fusegen Therapeutics Llp.
The current boards of Harshal Kanubhai Shah's companies include Vijay Kumar Ranka (Fusegen Therapeutics Llp), Narendra Prabhudas Chotai (Forefront Pharmalabs Private Limited).